These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 24405537)

  • 61. Total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine as a conditioning regimen in allogeneic hematopoietic stem cell transplantation for advanced myelodysplastic syndrome: a single-institute experience.
    Mori T; Aisa Y; Yokoyama A; Nakazato T; Yamazaki R; Shimizu T; Mihara A; Kato J; Watanabe R; Takayama N; Ikeda Y; Okamoto S
    Bone Marrow Transplant; 2007 Feb; 39(4):217-21. PubMed ID: 17220902
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Improved outcome in patients with chronic myelogenous leukemia after allogeneic hematopoietic stem cell transplantation over the past 25 years: a single-center experience.
    Boehm A; Walcherberger B; Sperr WR; Wöhrer S; Dieckmann K; Rosenmayr A; Pernicka E; Fischer G; Worel N; Mitterbauer G; Schwarzinger I; Mitterbauer M; Haas OA; Lechner K; Hinterberger W; Valent P; Greinix HT; Rabitsch W; Kalhs P
    Biol Blood Marrow Transplant; 2011 Jan; 17(1):133-40. PubMed ID: 20601032
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.
    McClune BL; Weisdorf DJ; Pedersen TL; Tunes da Silva G; Tallman MS; Sierra J; Dipersio J; Keating A; Gale RP; George B; Gupta V; Hahn T; Isola L; Jagasia M; Lazarus H; Marks D; Maziarz R; Waller EK; Bredeson C; Giralt S
    J Clin Oncol; 2010 Apr; 28(11):1878-87. PubMed ID: 20212255
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A Randomized Study Comparing Stem Cell Transplantation Versus Conventional Therapy for Low- and Intermediate-Risk Myelodysplastic Syndromes Patients.
    Yu ZP; Ding JH; Sun AN; Ge Z; Chen BA; Wu DP
    Stem Cells Dev; 2017 Aug; 26(15):1132-1139. PubMed ID: 28494646
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [The influence of liver dysfunction before transplantation and during conditioning period on the outcome of allogeneic hematopoietic stem cell transplantation].
    Zhao J; Ren H; Qiu Z; Wang M; Liu W; Xu W; Li Y; Sun Y; Wang L; Liang Z; Dong Y; Ou J; Wang W; Yin Y; Cen X; Wang Q
    Zhonghua Nei Ke Za Zhi; 2014 Feb; 53(2):99-103. PubMed ID: 24767159
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Reduced-intensity conditioning therapy with fludarabine, idarubicin, busulfan and cytarabine for allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.
    Gao L; Gao L; Gong Y; Zhang C; Chen XH; Zhang X
    Leuk Res; 2013 Nov; 37(11):1482-7. PubMed ID: 24054720
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intravenous busulfan-cyclophosphamide as a preparative regimen before allogeneic hematopoietic stem cell transplantation for adult patients with acute lymphoblastic leukemia.
    Tang W; Wang L; Zhao WL; Chen YB; Shen ZX; Hu J
    Biol Blood Marrow Transplant; 2011 Oct; 17(10):1555-61. PubMed ID: 21549217
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Allogeneic hematopoietic stem cell transplantation in adolescent and adult patients with high-risk T cell acute lymphoblastic leukemia.
    Bakr M; Rasheed W; Mohamed SY; Al-Mohareb F; Chaudhri N; Al-Sharif F; Al-Zahrani H; Al-Dawsari G; Saleh AJ; Nassar A; Ahmed S; Elghazaly A; Ahmed SO; Ibrahim K; Chebbo W; El Gohary GM; Al Mahayni MH; Hussain F; Nurgat Z; Elhassan TA; Walter CU; Aljurf M
    Biol Blood Marrow Transplant; 2012 Dec; 18(12):1897-904. PubMed ID: 22824185
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
    Kebriaei P; Kline J; Stock W; Kasza K; Le Beau MM; Larson RA; van Besien K
    Bone Marrow Transplant; 2005 May; 35(10):965-70. PubMed ID: 15806131
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Myeloablative hematopoietic stem cell transplantation for myelodysplastic syndrome in patients younger than 55 years: impact of comorbidity and disease burden on the long-term outcome.
    Kanamori H; Enaka M; Ito S; Motohashi K; Hagihara M; Oshima R; Sakai R; Fujisawa S; Tanaka M; Fujimaki K; Fujita H; Ishigatsubo Y; Maruta A
    Int J Lab Hematol; 2010 Apr; 32(2):222-9. PubMed ID: 19573175
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Hemopoietic cell transplantation for the myelodysplastic syndromes.
    Scott BL; Deeg HJ
    Arch Immunol Ther Exp (Warsz); 2005; 53(4):297-307. PubMed ID: 16088314
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Improved outcomes of allogeneic hematopoietic stem cell transplantation including haploidentical transplantation for childhood myelodysplastic syndrome.
    Yoo JW; Im HJ; Kim H; Koh KN; Kang SH; Min SY; Choi ES; Jang S; Park CJ; Seo JJ
    Bone Marrow Transplant; 2020 Aug; 55(8):1595-1603. PubMed ID: 32054998
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Moderate to Severe Marrow Fibrosis As a More Advanced Risk Factor for MDS and MDS-AML Patients With Excess of Blasts Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Wang J; Wang Q; Zhang H; He Y; Huang Y; Zhang R; Wei J; Ma Q; Pang A; Yang D; Chen X; Jiang E; Feng S; Zhai W; Han M
    Transplant Cell Ther; 2021 Aug; 27(8):666.e1-666.e9. PubMed ID: 34020086
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Treatment of adult ALL with central nervous system involvement at diagnosis using autologous and allogeneic transplantation: a study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
    Chantepie SP; Mohty M; Tabrizi R; Robin M; Deconinck E; Buzyn A; Contentin N; Raus N; Lhéritier V; Reman O
    Bone Marrow Transplant; 2013 May; 48(5):684-90. PubMed ID: 23165497
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term follow-up of allogeneic hematopoietic stem cell transplantation for de novo acute myelogenous leukemia with a conditioning regimen of total body irradiation and granulocyte colony-stimulating factor-combined high-dose cytarabine.
    Mori T; Aisa Y; Watanabe R; Yamazaki R; Kato J; Shimizu T; Shigematsu N; Kubo A; Yajima T; Hibi T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):651-7. PubMed ID: 18489990
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes.
    Lim ZY; Pearce L; Ho AY; Barber L; Ingram W; Usai M; Tobal K; Devereux S; Pagliuca A; Mufti GJ
    Br J Haematol; 2007 Aug; 138(4):517-26. PubMed ID: 17608767
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Hematopoietic stem cell transplantation in the myelodisplastic syndromes].
    León-Rodríguez E
    Rev Invest Clin; 2005; 57(2):283-90. PubMed ID: 16524069
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Impact of HLA compatibility on the outcome of allogeneic hematopoietic stem cell transplantation for chronic myeloid leukemia].
    ZHANG Y; CHEN YK; FAN ZP; XU D; JIANG QL; SUN J; LIU QF
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):438-42. PubMed ID: 21421478
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Contribution of Revised International Prognostic Scoring System Cytogenetics to Predict Outcome After Allogeneic Stem Cell Transplantation for Myelodysplastic Syndromes: A Study From the French Society of Bone Marrow Transplantation and Cellular Therapy.
    Gauthier J; Damaj G; Langlois C; Robin M; Michallet M; Chevallier P; Beguin Y; N'guyen S; Bories P; Blaise D; Cornillon J; Clavert A; Mohty M; Huynh A; Thiébaut-Bertrand A; Vigouroux S; Duhamel A; Yakoub-Agha I
    Transplantation; 2015 Aug; 99(8):1672-80. PubMed ID: 25769079
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Myelodysplastic Syndrome Harboring Trisomy 8.
    Konuma T; Miyazaki Y; Uchida N; Ohashi K; Kondo T; Nakamae H; Takahashi S; Mori T; Ozawa Y; Kato C; Iwato K; Fukuda T; Ichinohe T; Atsuta Y; Ishiyama K;
    Biol Blood Marrow Transplant; 2017 Jan; 23(1):75-80. PubMed ID: 27777139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.